ArticleBiomaterials and biosystems2026
Zone of inhibition prediction in silver nanoparticle antimicrobial activity via physics-guided liquid state machine.
Article in Biomaterials and biosystems, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Silver nanoparticles are widely applied in medicine, packaging, and environmental remediation because of their potent antimicrobial properties. Nevertheless, predictive modeling of their zone of inhibition (ZOI) remains a longstanding challenge due to limited experimental datasets and the lack of physical consistency in machine learning approaches. In this study, a physics-guided liquid state machine (PG-LSM) was developed, integrating key physics-informed features of nanoparticle formation with experimental ZOI data through a series of reservoirs to predict antimicrobial efficacy. Three pretrained reservoirs of particle shape, particle core size, and ultraviolet-visible peak are transferred as encoders into a terminal ZOI predictor. Across nine baseline models, PG-LSM achieved the strongest test performance with a coefficient of determination (R²) of 0.956, a root mean square error (RMSE) of 1.151, and a mean absolute error (MAE) of 0.486 with close agreement between validation and test scores, indicating reliable generalization under small-sample conditions. Ablation studies confirmed the additive value from each reservoir; removing any intermediate stage degraded accuracy and stability. SHAP analysis revealed that exposure dose concentration and duration dominated the antimicrobial activity of AgNPs, whereas microbial species, capping agent, and reducing agent had a lower impact. PG-LSM advances materials informatics for AgNP antimicrobial assessment through physics-guided embeddings integrated with reservoir computing. The framework delivers accurate, stable, and interpretable ZOI predictions and remains practical for limited datasets.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.